143 related articles for article (PubMed ID: 183462)
1. Clofibrate in type II hyperlipoproteinemia.
Ditzel J; Bang HO
Acta Med Scand; 1976; 200(1-2):55-58. PubMed ID: 183462
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL
J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715
[No Abstract] [Full Text] [Related]
3. One-year trials with halofenate, clofibrate, and placebo.
Dujovne CA; Azarnoff DL; Huffman DH; Pentikäinen P; Hurwitz A; Shoeman DW
Clin Pharmacol Ther; 1976 Mar; 19(3):352-9. PubMed ID: 177242
[TBL] [Abstract][Full Text] [Related]
4. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Vessby B; Lithell H; Gustafsson IB; Borberg J
Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
[TBL] [Abstract][Full Text] [Related]
5. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
Rouffy J; Dreux C; Goussault Y; Dakkak R; Renson FJ
Arzneimittelforschung; 1976; 26(5):901-6. PubMed ID: 183788
[TBL] [Abstract][Full Text] [Related]
6. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
[TBL] [Abstract][Full Text] [Related]
7. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
Jung W; Kremer GJ; Müller D
MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
Jantke J; Schwartzkopff W; Zschiedrich M
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057
[No Abstract] [Full Text] [Related]
9. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
[TBL] [Abstract][Full Text] [Related]
10. Serum lipoprotein composition in different types of hyperlipoproteinemia.
Carlson LA
Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Arntz HR; Klemens UH; Vollmar LJ; Lang PD
Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Gaertner U; Johannes KJ
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
[TBL] [Abstract][Full Text] [Related]
13. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
Miettinen TA; Penttilä IM; Lampainen E
Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
[No Abstract] [Full Text] [Related]
14. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
[No Abstract] [Full Text] [Related]
15. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
Krivoruchenko IV; Nikul'cheva NG
Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448
[TBL] [Abstract][Full Text] [Related]
16. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Patsch JR; Yeshurun D; Jackson RL; Gotto AM
Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
[No Abstract] [Full Text] [Related]
17. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
[No Abstract] [Full Text] [Related]
19. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
Weisweiler P; Schwandt P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
[No Abstract] [Full Text] [Related]
20. Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
Bielmann P; Brun D; Moorjani S; Gagnon MA; Tétreault L; Lupien PJ
Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):166-71. PubMed ID: 192685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
